|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 74.70 USD | -0.13% |
|
+0.25% | +26.23% |
| 07-16 | Ingevity Receives BASt Approval For Evotherm P35 Warm-Mix Additive In Germany | CI |
| 06-25 | Ingevity Names Ryan Cotterman as Chief Accounting Officer | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 89 | +18.98% | 3 | ||||||
| 8,074.71 | +12.07% | 17 | ||||||
| 52.26 | +8.33% | 21 | ||||||
| 1,652.9 | +3.87% | 21 | ||||||
| 1,944.17 | +4.41% | 12 | ||||||
| 1,189.09 | -0.33% | 11 | ||||||
| 56.57 | -2.7% | 14 | ||||||
| 2,967.6 | +0.89% | 30 | ||||||
| 71.35 | +2.96% | 17 | ||||||
| 203.11 | +7.32% | 9 | ||||||
| 8,311.11 | +5.02% | 9 | ||||||
| 23.61 | +11.68% | 16 | ||||||
| 663.33 | +23.66% | 9 | ||||||
| 3,092.22 | +11.77% | 9 | ||||||
| - | - | 39 | +29.44% | 1 | ||||
| 2,704.1 | -26.46% | 10 | ||||||
| 70 | +2.17% | 11 | ||||||
| 25.01 | -3.72% | 15 | ||||||
| 184.5 | +28.27% | 4 | ||||||
| Average | 1,653.35 | +7.24% | 13 | ||||||
| Weighted average by Cap. | 3,411.07 | +8.30% | 16 |
- Stock Market
- Stocks
- NGVT Stock
- Sector Ingevity Corporation
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
